Understanding Cancer Stem Cell Heterogeneity and Plasticity

Overview

Journal Cell Res

Specialty Cell Biology

Date 2012 Feb 24

PMID 22357481

Citations 297

Authors

Dean G Tang

Affiliations

Soon will be listed here.

Abstract

Heterogeneity is an omnipresent feature of mammalian cells in vitro and in vivo. It has been recently realized that even mouse and human embryonic stem cells under the best culture conditions are heterogeneous containing pluripotent as well as partially committed cells. Somatic stem cells in adult organs are also heterogeneous, containing many subpopulations of self-renewing cells with distinct regenerative capacity. The differentiated progeny of adult stem cells also retain significant developmental plasticity that can be induced by a wide variety of experimental approaches. Like normal stem cells, recent data suggest that cancer stem cells (CSCs) similarly display significant phenotypic and functional heterogeneity, and that the CSC progeny can manifest diverse plasticity. Here, I discuss CSC heterogeneity and plasticity in the context of tumor development and progression, and by comparing with normal stem cell development. Appreciation of cancer cell plasticity entails a revision to the earlier concept that only the tumorigenic subset in the tumor needs to be targeted. By understanding the interrelationship between CSCs and their differentiated progeny, we can hope to develop better therapeutic regimens that can prevent the emergence of tumor cell variants that are able to found a new tumor and distant metastases.

Citing Articles

CD44 cells enhance pro-tumor stroma in the spatial landscape of colorectal cancer leading edge.

Tang F, Zhu Y, Shen J, Yuan B, He X, Tian Y Br J Cancer. 2025; .

PMID: 40069574 DOI: 10.1038/s41416-025-02968-9.

Revisiting ABC Transporters and Their Clinical Significance in Glioblastoma.

Phon B, Chelliah S, Osman D, Bhuvanendran S, Radhakrishnan A, Kamarudin M Pharmaceuticals (Basel). 2025; 18(1).

PMID: 39861164 PMC: 11769420. DOI: 10.3390/ph18010102.

Adenosinergic Signalling in Cervical Cancer Microenvironment.

Iser I, Bertoni A, Beckenkamp L, Consolaro M, Maria-Engler S, Wink M Expert Rev Mol Med. 2025; 27():e5.

PMID: 39762204 PMC: 11707834. DOI: 10.1017/erm.2024.30.

Comprehensive review of drug resistance in mammalian cancer stem cells: implications for cancer therapy.

Mengistu B, Tsegaw T, Demessie Y, Getnet K, Bitew A, Kinde M Cancer Cell Int. 2024; 24(1):406.

PMID: 39695669 PMC: 11657890. DOI: 10.1186/s12935-024-03558-0.

MetaPhenotype: A Transferable Meta-Learning Model for Single-Cell Mass Spectrometry-Based Cell Phenotype Prediction Using Limited Number of Cells.

Yao S, Nguyen T, Lan Y, Yang W, Chen D, Shao Y Anal Chem. 2024; 96(49):19238-19247.

PMID: 39570119 PMC: 11673283. DOI: 10.1021/acs.analchem.4c02038.

References

Yu F, Yao H, Zhu P, Zhang X, Pan Q, Gong C . let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell. 2007; 131(6):1109-23. DOI: 10.1016/j.cell.2007.10.054. View

Yoo A, Sun A, Li L, Shcheglovitov A, Portmann T, Li Y . MicroRNA-mediated conversion of human fibroblasts to neurons. Nature. 2011; 476(7359):228-31. PMC: 3348862. DOI: 10.1038/nature10323. View

Hong S, Rampalli S, Lee J, McNicol J, Collins T, Draper J . Cell fate potential of human pluripotent stem cells is encoded by histone modifications. Cell Stem Cell. 2011; 9(1):24-36. DOI: 10.1016/j.stem.2011.06.002. View

Piccirillo S, Combi R, Cajola L, Patrizi A, Redaelli S, Bentivegna A . Distinct pools of cancer stem-like cells coexist within human glioblastomas and display different tumorigenicity and independent genomic evolution. Oncogene. 2009; 28(15):1807-11. DOI: 10.1038/onc.2009.27. View

Liu C, Kelnar K, Liu B, Chen X, Calhoun-Davis T, Li H . The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat Med. 2011; 17(2):211-5. PMC: 3076220. DOI: 10.1038/nm.2284. View

Mani S, Guo W, Liao M, Eaton E, Ayyanan A, Zhou A . The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008; 133(4):704-15. PMC: 2728032. DOI: 10.1016/j.cell.2008.03.027. View

Quintana E, Shackleton M, Sabel M, Fullen D, Johnson T, Morrison S . Efficient tumour formation by single human melanoma cells. Nature. 2008; 456(7222):593-8. PMC: 2597380. DOI: 10.1038/nature07567. View

Cotsarelis G, Cheng S, Dong G, Sun T, Lavker R . Existence of slow-cycling limbal epithelial basal cells that can be preferentially stimulated to proliferate: implications on epithelial stem cells. Cell. 1989; 57(2):201-9. DOI: 10.1016/0092-8674(89)90958-6. View

Su Y, Lai H, Chang Y, Chen G, Lee J . Direct reprogramming of stem cell properties in colon cancer cells by CD44. EMBO J. 2011; 30(15):3186-99. PMC: 3160185. DOI: 10.1038/emboj.2011.211. View

10.

Medema J, Vermeulen L . Microenvironmental regulation of stem cells in intestinal homeostasis and cancer. Nature. 2011; 474(7351):318-26. DOI: 10.1038/nature10212. View

11.

Visvader J . Cells of origin in cancer. Nature. 2011; 469(7330):314-22. DOI: 10.1038/nature09781. View

12.

Dalerba P, Dylla S, Park I, Liu R, Wang X, Cho R . Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci U S A. 2007; 104(24):10158-63. PMC: 1891215. DOI: 10.1073/pnas.0703478104. View

13.

Jeter C, Liu B, Liu X, Chen X, Liu C, Calhoun-Davis T . NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation. Oncogene. 2011; 30(36):3833-45. PMC: 3140601. DOI: 10.1038/onc.2011.114. View

14.

Ishizawa K, Rasheed Z, Karisch R, Wang Q, Kowalski J, Susky E . Tumor-initiating cells are rare in many human tumors. Cell Stem Cell. 2010; 7(3):279-82. PMC: 2945729. DOI: 10.1016/j.stem.2010.08.009. View

15.

Paranjape A, Mandal T, Mukherjee G, Kumar M, Sengupta K, Rangarajan A . Introduction of SV40ER and hTERT into mammospheres generates breast cancer cells with stem cell properties. Oncogene. 2011; 31(15):1896-909. DOI: 10.1038/onc.2011.378. View

16.

Inda M, Bonavia R, Mukasa A, Narita Y, Sah D, Vandenberg S . Tumor heterogeneity is an active process maintained by a mutant EGFR-induced cytokine circuit in glioblastoma. Genes Dev. 2010; 24(16):1731-45. PMC: 2922502. DOI: 10.1101/gad.1890510. View

17.

Notta F, Doulatov S, Laurenti E, Poeppl A, Jurisica I, Dick J . Isolation of single human hematopoietic stem cells capable of long-term multilineage engraftment. Science. 2011; 333(6039):218-21. DOI: 10.1126/science.1201219. View

18.

Jeter C, Badeaux M, Choy G, Chandra D, Patrawala L, Liu C . Functional evidence that the self-renewal gene NANOG regulates human tumor development. Stem Cells. 2009; 27(5):993-1005. PMC: 3327393. DOI: 10.1002/stem.29. View

19.

Bonavia R, Inda M, Cavenee W, Furnari F . Heterogeneity maintenance in glioblastoma: a social network. Cancer Res. 2011; 71(12):4055-60. PMC: 3117065. DOI: 10.1158/0008-5472.CAN-11-0153. View

20.

Hendrix M, Seftor E, Hess A, Seftor R . Molecular plasticity of human melanoma cells. Oncogene. 2003; 22(20):3070-5. DOI: 10.1038/sj.onc.1206447. View